PHASE GENOMICS, INC.

PHASE GENOMICS, INC. is a biotech company in Seattle, United States, founded in 2016. It has raised $5.0M across 4 rounds, most recently a $1.5M Grant in March 2024.

Blueprints for Biology

Employees
1–10
Founded
2016
Business Model
B2B
Total Funding
$5.0M
Last Round
$1.5M GrantMar 2024
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 3 investors for this company. The full record is or through the API.

About

Phase Genomics is a life science company that develops proximity ligation (Hi-C) technology for ultra-long-range genome sequencing, enabling chromosome-scale genome assembly, metagenomic deconvolution, and structural variant analysis. The company offers laboratory kits for plants, animals, microbes, and human samples alongside industry-leading bioinformatics software platforms including CytoTerra, ProxiMeta, and Proximo. Founded in 2015 in Seattle, Phase Genomics serves applications in oncology, genetic disease, metagenomics, and microbiology.

Summary

It lists 1–10 employees. It has raised $5.0M in total across 4 rounds, most recently a $1.5M Grant round in Mar 2024. Investors include Alliance of Angels, Bill & Melinda Gates Foundation and National Cancer Institute.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
GrantMar 2024
$1.5M

Sign up to see all 4 events

Funding: Seed through Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
GRAILIPO

Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...

Menlo Park, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$2.1BJun 2026
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

PHASE GENOMICS, INC. on Indexed.vc
<a href="https://indexed.vc/companies/phase-genomics-inc"><img src="https://indexed.vc/api/badge/company/phase-genomics-inc" alt="PHASE GENOMICS, INC. on Indexed.vc" width="260" height="76" /></a>